• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

Prostate Cancer: National Guidelines Have Not Stopped Overuse of Low-Value PSA Screening in Older Males

Prostate Cancer: National Guidelines Have Not Stopped Overuse of Low-Value PSA Screening in Older Males

by Glenn S. Demby | May 25, 2023 | Diagnostic Testing and Emerging Technologies, Special Focus-dtet

New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.

This content is for Paid Members only.
Login Register
AACC Offers New Guidance for HPV and Cervical Cancer Screening

AACC Offers New Guidance for HPV and Cervical Cancer Screening

by Glenn S. Demby | Apr 24, 2023 | Diagnostic Testing and Emerging Technologies, Special Focus-dtet

New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.

This content is for Paid Members only.
Login Register
New Guidance Released for Cervical Cancer Detection

New Guidance Released for Cervical Cancer Detection

by Rachel Muenz | Mar 21, 2023 | News

Recently released AACC document covers newly updated screening guidelines as well as information on surveillance and diagnosis.

CMS Clarifies Rules for IDTF Medicare Billing of Diagnostic Tests

CMS Clarifies Rules for IDTF Medicare Billing of Diagnostic Tests

by Glenn S. Demby | Mar 10, 2023 | Guidelines at a Glance-nir, National Lab Reporter

The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.

This content is for Paid Members only.
Login Register
USPSTF Again Declines to Recommend Lipid Screening for Asymptomatic Children

USPSTF Again Declines to Recommend Lipid Screening for Asymptomatic Children

by Glenn S. Demby | Feb 21, 2023 | Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

The panel recently said there was still not enough evidence to properly assess the harms and benefits of such screening.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com